Clinical Trials / Research Studies

Other Neurofibromatosis Trials

Brain and Spinal Tumors Research Studies

< Back to Young Adult Cancer Research Studies Page

Other Neurofibromatosis Trials

A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration

  • Ages: 1 year and ≤ 30 years old

This phase I/II trial studies the side effects and best dose of adding hydroxychloroquine to dabrafenib and/or trametinib, and to see how well they work in treating children with low grade or high grade brain tumors previously treated with similar drugs that did not respond completely (progressive) ...More